Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis

We conducted a pooled analysis of two phase III trials, RV-MM-EMN-441 and EMN01, to compare maintenance with lenalidomide-prednisone vs. lenalidomide in newly diagnosed transplant-eligible and -ineligible myeloma patients. Primary endpoints were progression-free survival, progression-free survival 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonello, Francesca, Pulini, Stefano, Ballanti, Stelvio, Gentile, Massimo, Spada, Stefano, Annibali, Ombretta, Omedé, Paola, Ronconi, Sonia, Cangialosi, Clotilde, Podda, Luigi, Palmas, Angelo, Malfitano, Alessandra, Rivoli, Giulia, Belotti, Angelo, Ciambelli, Fabrizio, Vincelli, Iolanda Donatella, Cafro, Anna Maria, Innao, Vanessa, Palumbo, Antonio, Sonneveld, Pieter, Spencer, Andrew, Hájek, Roman, Boccadoro, Mario, Gay, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896192/
https://www.ncbi.nlm.nih.gov/pubmed/31694338
http://dx.doi.org/10.3390/cancers11111735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896192/
https://www.ncbi.nlm.nih.gov/pubmed/31694338
http://dx.doi.org/10.3390/cancers11111735

Ejemplares similares